As we talked about, the oral compounds that we have launched, that is that in and about itself is the fastest growing specialty weve ever launched on the platform, achieving north of $100 million run rate just in 6 or 7 months
At the secondary outcome endpoint (weight loss + cardiovascular benefit), the scores for exenatide, liraglutide, lixisenatide, benaglutide, dulaglutide, PEG loxenatide, and semaglutide were 2, 3, 1.5, 0, 2.5, 0, and 4, respectively
I wanted a provider who would look at my hormones, my history of PCOS, my stress, my sleep the full picture
Esta hormona es sintetizada en las clulas L del intestino durante nuestro proceso digestivo (de hecho, su secrecin depende de la presencia de nutrientes en la luz del intestino delgado)
When your first-month tracking should become a clinician conversation Most first-month tracking is about patterns